Publications by authors named "J Cristobal Vera"

Introduction: Depressive symptoms are highly prevalent among people with HIV, which can negatively impact HIV-related outcomes. We explore the cascade of mental healthcare for people with HIV experiencing depressive symptoms.

Methods: People with HIV who were part of the Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) study (2013-2016) were included.

View Article and Find Full Text PDF

Glaucoma is a group of eye diseases characterized by progressive harm to the optic nerve that often results in loss of vision and blindness. Recent studies suggest that deregulation in the expression of a particular type of RNAs named long noncoding RNAs (lncRNAs) can impact the development of glaucoma and, hence, are promising targets for drug discovery. LncRNAs are transcripts with a length longer than 200 nucleotides that are not translated into proteins.

View Article and Find Full Text PDF

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression. They have been associated with several diseases and cancers, including chronic lymphocytic leukemia (CLL). CLL is the most common form of adult leukemia, and its pathogenesis is driven by the deletion of miRNAs, such as the miR-15a/16-1 cluster.

View Article and Find Full Text PDF

Moderated nonlinear factor analysis (MNLFA) has emerged as an important and flexible data analysis tool, particularly in integrative data analysis setting and psychometric studies of measurement invariance and differential item functioning. Substantive applications abound in the literature and span a broad range of disciplines. MNLFA unifies item response theory, multiple group, and multiple indicator multiple cause modeling traditions, and it extends these frameworks by conceptualizing latent variable heterogeneity as a source of differential item functioning.

View Article and Find Full Text PDF

Background: The twice-yearly, long-acting lenacapavir (LA LEN) antiretroviral therapy (ART), when combined with an optimised background regimen, provides a subcutaneous injectable treatment option for people with HIV. This study aimed to understand the preferences, barriers and facilitators for uptake and implementation of LA LEN, with a view to informing clinical implementation.

Methods: In-depth qualitative interviews and focus groups with purposively sampled people with HIV and healthcare workers (HCWs) from UK HIV services were conducted.

View Article and Find Full Text PDF